Effectiveness between the adalimumab biosimilars (Amjevita and Imraldi) and the original brand-name version (Humira) was comparable both in new users and for patients switching from the original ...

While Humira faces further erosion due to biosimilar ... provides easy-to-follow model portfolios designed for wealth accumulation. Curious if ABBV is one of these AI-selected gems?

Optimizing Humira coverage is not just about reducing costs—it's about delivering effective, compassionate care while ...

Novartis is looking to take full advantage of its branded and generics/biosimilar business model, with Cosentyx and a Humira biosimilar will help it provide a broader offering. "When patients are ...

By partnering directly with manufacturers, the insurer aims to dramatically reduce the price of AbbVie's Humira, the ... introduces a new model called Pharmacy Care Reimagined.